Effects of direct-acting antiviral treatment of chronic hepatitis C on macrophage activation, liver stiffness, metabolic liver function and portal hypertension in cirrhosis patients

T.L. Laursen, K. Kazankov, T.D. Sandahl, H.J. Møller, L. Hagelskjær Kristensen, C. Holmboe, C. Sølund, H. Arildsen, A. Laursen, H. Grønbæk

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
ArtikelnummerFRI-399
TidsskriftJournal of Hepatology
Vol/bind68
Udgave nummerSuppl. 1
Sider (fra-til)S541
ISSN0168-8278
DOI
StatusUdgivet - apr. 2018
BegivenhedThe International Liver Congress 2018 - Paris, Frankrig
Varighed: 11 apr. 201815 apr. 2018

Konference

KonferenceThe International Liver Congress 2018
LandFrankrig
ByParis
Periode11/04/201815/04/2018

Citationsformater

Laursen, T. L., Kazankov, K., Sandahl, T. D., Møller, H. J., Hagelskjær Kristensen, L., Holmboe, C., Sølund, C., Arildsen, H., Laursen, A., & Grønbæk, H. (2018). Effects of direct-acting antiviral treatment of chronic hepatitis C on macrophage activation, liver stiffness, metabolic liver function and portal hypertension in cirrhosis patients. Journal of Hepatology, 68(Suppl. 1), S541. [FRI-399]. https://doi.org/10.1016/S0168-8278(18)31339-4